PT  - JOURNAL ARTICLE
AU  - Zhai, Yunkai
AU  - Wang, Yichuan
AU  - Zhang, Minhao
AU  - Gittell, Jody Hoffer
AU  - Jiang, Shuai
AU  - Chen, Baozhan
AU  - Cui, Fangfang
AU  - He, Xianying
AU  - Zhao, Jie
AU  - Wang, Xiaojun
TI  - From Isolation to Coordination: How Can Telemedicine Help Combat the COVID-19 Outbreak?
AID  - 10.1101/2020.02.20.20025957
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.02.20.20025957
4099  - http://medrxiv.org/content/early/2020/02/23/2020.02.20.20025957.short
4100  - http://medrxiv.org/content/early/2020/02/23/2020.02.20.20025957.full
AB  - The rapid spread of Coronavirus disease 2019 (COVID-19) presents China with a critical challenge. As normal capacity of the Chinese hospitals is exceeded, healthcare professionals struggling to manage this unprecedented crisis face the difficult question of how best to coordinate the medical resources used in highly separated locations. Responding rapidly to this crisis, the National Telemedicine Center of China (NTCC), located in Zhengzhou, Henan Province, has established the Emergency Telemedicine Consultation System (ETCS), a telemedicine-enabled outbreak alert and response network. ETCS is built upon a doctor-to-doctor (D2D) approach, in which health services can be accessed remotely through terminals across hospitals. The system architecture of ETCS comprises three major architectural layers: (1) telemedicine service platform layer, (2) telemedicine cloud layer, and (3) telemedicine service application layer. Our ETCS has demonstrated substantial benefits in terms of the effectiveness of consultations and remote patient monitoring, multidisciplinary care, and prevention education and training.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has been funded by Novel Coronavirus Pneumonia Prevention and Control Headquarters (NCPPCH) and the Finance Department of Henan ProvinceAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors confirm that the data supporting the findings of this study are available within the article.